DA-8031

DB19024InvestigationalSmall molecule

DA-8031 is under investigation in clinical trial NCT01798667 (Clinical Trial to Evaluate the Efficacy and Safety of DA-8031 in Male Patients With Premature Ejaculation).

Mechanism: Pharmacologically active on Sodium-dependent serotonin transporter
Curator reviewed
Formula / weight: C₂₁H₂₄N₂O₂ · 336.435 g/mol (avg)
Also known as: 1-(3-(DIMETHYLAMINO)PROPYL)-1,3-DIHYDRO-1-(4-METHOXYPHENYL)-5-ISOBENZOFURANCARBONITRILE · 5-ISOBENZOFURANCARBONITRILE, 1-(3-(DIMETHYLAMINO)PROPYL)-1,3-DIHYDRO-1-(4-METHOXYPHENYL)- · ISOBENZOFURANCARBONITRILE
Code names: DA-8031

Resolves to

Compound

UNIIVN9EXL272YCAS1148027-74-0ChEMBLCHEMBL5095175

Structure

InChIKeyRCMIUWUYNFSCAE-UHFFFAOYSA-NSMILESCOC1=CC=C(C=C1)C1(CCCN(C)C)OCC2=CC(=CC=C12)C#N

Targets

P31645SLC6A4

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with DA-8031, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account